{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:15:58Z","timestamp":1790396158809,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1991,1]]},"DOI":"10.1007\/bf01806369","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T20:16:42Z","timestamp":1119903402000},"page":"197-210","source":"Crossref","is-referenced-by-count":59,"title":["Multiple actions of synthetic \u2018progestins\u2019 on the growth of ZR-75-1 human breast cancer cells: Anin vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids"],"prefix":"10.1007","volume":"17","author":[{"given":"Richard","family":"Poulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernand","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"suppl","key":"BF01806369_CR1","first-page":"2","volume":"13","author":"DG Haller","year":"1986","unstructured":"Haller DG, Glick JH: Progestational agents in advanced breast cancer: an overview. Semin Oncol 13 (suppl): 2\u20138, 1986","journal-title":"Semin Oncol"},{"key":"BF01806369_CR2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","volume":"25","author":"BJA Furr","year":"1984","unstructured":"Furr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127\u2013205, 1984","journal-title":"Pharmacol Ther"},{"key":"BF01806369_CR3","first-page":"249","volume":"41","author":"KB Horwitz","year":"1985","unstructured":"Horwitz KB, Wei LL, Sedlacek SM, d'Arville CN: Progestin action and progesterone receptor structure in human breast cancer: a review: Rec Progr Horm Res 41: 249\u2013316, 1985","journal-title":"Rec Progr Horm Res"},{"key":"BF01806369_CR4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1126\/science.137.3526.257","volume":"137","author":"C Huggins","year":"1962","unstructured":"Huggins C, Yang NC: Induction and extinction of mammary cancer. Science 137: 257\u2013262, 1962","journal-title":"Science"},{"key":"BF01806369_CR5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bjc.1973.8","volume":"27","author":"AG Jabara","year":"1973","unstructured":"Jabara AG: Effects of progesterone of 9,10-dimethylbenz-(a)anthracene in Sprague-Dawley rats. Br J Cancer 27: 63\u201371, 1973","journal-title":"Br J Cancer"},{"key":"BF01806369_CR6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/endo-101-3-666","volume":"101","author":"J Asselin","year":"1977","unstructured":"Asselin J, Kelly PA, Caron MG, Labrie F: Control of hormone receptor levels and growth of 7,12-dimethylbenz-(a)anthracene-induced mammary tumors by estrogens, progesterone, and prolactin. Endocrinology 101: 666\u2013671, 1977","journal-title":"Endocrinology"},{"key":"BF01806369_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0022-4731(81)90308-3","volume":"15","author":"BS Leung","year":"1981","unstructured":"Leung BS, Potter AH, Qureshi S: Interactions of prolactin, estrogen, and progesterone in a human mammary carcinoma cell line, CAMA-1-I. Cell growth and thymidine uptake. J Steroid Biochem 15: 421\u2013427, 1981","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0006-291X(87)91022-9","volume":"145","author":"JR Hissom","year":"1987","unstructured":"Hissom JR, Moore MR: Progestin effects on growth in the human breast cancer cell line T-47D possible therapeutic implications. Biochem Biophys Res Commun 145: 706\u2013711, 1987","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01806369_CR9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1210\/jcem-56-6-1124","volume":"56","author":"F Vignon","year":"1983","unstructured":"Vignon F, Bardon S, Chalbos D, Rochefort H: Antiestrogenic effect of R5020, a synthetic progestin human breast cancer cells in culture. J Clin Endocrinol Metab 56: 1124\u20131130, 1983","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806369_CR10","first-page":"167","volume":"45","author":"KB Horwitz","year":"1985","unstructured":"Horwitz KB, Freidenberg GR: Growth inhibition and increase of insulin receptor in antiestrogen-resistant T47Dco human breast cancer cells by \u2018progestins\u2019: implications for endocrine therapies. Cancer Res 45: 167\u2013173, 1985","journal-title":"Cancer Res"},{"key":"BF01806369_CR11","first-page":"3352","volume":"38","author":"LW Engel","year":"1978","unstructured":"Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 38: 3352\u20133364, 1978","journal-title":"Cancer Res"},{"key":"BF01806369_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02106576","volume":"13","author":"R Poulin","year":"1989","unstructured":"Poulin R, Dufour JM, Labrie F: Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin. Breast Cancer Res Treat 13: 265\u2013276, 1989","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806369_CR13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0015-0282(16)42864-5","volume":"28","author":"F Labrie","year":"1977","unstructured":"Labrie F, Ferland L, Lagac\u00e9 L, Drouin J, Asselin J, Azadian-Boulanger G, Raynaud JP: High inhibitory activity of R5020, a pure progestin, at the hypothalamic-adenohypophyseal level on gonadotropin secretion. Fertil Steril 28: 1104\u20131112, 1977","journal-title":"Fertil Steril"},{"key":"BF01806369_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-349-81345-2_11","volume-title":"Mechanisms of Steroid Action","author":"JP Raynaud","year":"1981","unstructured":"Raynaud JP, Ojasoo T, Labrie F: Steroid hormones agonists and antagonists. In: Lewis GP, Grisburg M (eds) Mechanisms of Steroid Action. MacMillan Press, London 1981, pp 145\u2013158"},{"key":"BF01806369_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0303-7207(85)90059-0","volume":"42","author":"P Poyet","year":"1985","unstructured":"Poyet P, Labrie F: Comparison of the antiandrogenic\/androgenic activities of flutamide, cyproterone acetate, and megestrol acetate. Mol Cell Endocrinol 42: 283\u2013288, 1985","journal-title":"Mol Cell Endocrinol"},{"key":"BF01806369_CR16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0022-4731(87)91054-5","volume":"28","author":"C Labrie","year":"1987","unstructured":"Labrie C, Cusan L, Plante M, Lapointe S, Labrie F: Analysis of the androgenic activity of synthetic \u2018progestins\u2019 currently used in the treatment of prostate cancer. J Steroid Biochem 28: 379\u2013384, 1987","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01806528","volume":"13","author":"R Poulin","year":"1989","unstructured":"Poulin R, Baker D, Poirier D, Labrie F: Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res Treat 13: 161\u2013172, 1989","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806369_CR18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-4731(88)90295-6","volume":"31","author":"IA Luthy","year":"1988","unstructured":"Luthy IA, B\u00e9gin DJ, Labrie F: Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture. J Steroid Biochem 31: 845\u2013852, 1988","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0303-7207(90)90190-J","volume":"68","author":"C Labrie","year":"1990","unstructured":"Labrie C, Simard J, Zhao HF, Pelletier G, Labrie F: Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate. Mol Cell Endocrinol 68: 169\u2013179, 1990","journal-title":"Mol Cell Endocrinol"},{"key":"BF01806369_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/146642408510500102","volume":"105","author":"MC Pike","year":"1985","unstructured":"Pike MC, Chilvers C: Oral contraceptives and breast cancer: the current controversy. J Royal Soc Health 105: 5\u201310, 1985","journal-title":"J Royal Soc Health"},{"key":"BF01806369_CR21","first-page":"4933","volume":"46","author":"R Poulin","year":"1986","unstructured":"Poulin R, Labrie F: Stimulation of cell proliferation and estrogenic response by adrenal C19-\u03945-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res 46: 4933\u20134937, 1986","journal-title":"Cancer Res"},{"key":"BF01806369_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/edrv-8-1-29","volume":"8","author":"RB Dickson","year":"1987","unstructured":"Dickson RB, Lippman ME: Estrogenic stimulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 8: 29\u201343, 1987","journal-title":"Endocr Rev"},{"key":"BF01806369_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01805942","volume":"12","author":"R Poulin","year":"1988","unstructured":"Poulin R, Baker D, Labrie F: Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 12: 213\u2013225, 1988","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806369_CR24","first-page":"2422","volume":"39","author":"CK Osborne","year":"1979","unstructured":"Osborne CK, Monaco ME, Kahn CR, Huff K, Bronzert D, Lippman ME: Direct inhibition of growth and antagonism by glucocorticoids in human breast cancer cells in culture. Cancer Res 39: 2422\u20132428, 1979","journal-title":"Cancer Res"},{"key":"BF01806369_CR25","first-page":"5084","volume":"48","author":"RL Sutherland","year":"1988","unstructured":"Sutherland RL, Hall RE, Pang GYN, Musgrove EA, Clarke CL: Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res 48: 5084\u20135091, 1988","journal-title":"Cancer Res"},{"key":"BF01806369_CR26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bst0070565","volume":"7","author":"R Neri","year":"1979","unstructured":"Neri R, Peets E, Watnick A: Antiandrogenicity of flutamide and its metabolite SCH16423. Biochem Soc Trans 7: 565\u2013569, 1979","journal-title":"Biochem Soc Trans"},{"key":"BF01806369_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","volume":"44","author":"J Simard","year":"1986","unstructured":"Simard J, Luthy I, Guay J, B\u00e9langer A, Labrie F: Characteristics of the interaction of the antiandrogen Flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol 44: 261\u2013270, 1986","journal-title":"Mol Cell Endocrinol"},{"key":"BF01806369_CR28","first-page":"77","volume-title":"Adrenal Steroid Antagonism","author":"D Philibert","year":"1984","unstructured":"Philibert D: RU38486: an original multifaceted antihormonein vivo. In: Agarwal MK (ed) Adrenal Steroid Antagonism. Walter de Gruyter, Berlin, 1984, pp 77\u2013101"},{"key":"BF01806369_CR29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0022-4731(86)90109-3","volume":"24","author":"PA Danhaive","year":"1986","unstructured":"Danhaive PA, Rousseau GG: Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscle. J Steroid Biochem 24: 481\u2013487, 1986","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR30","doi-asserted-by":"crossref","unstructured":"L\u00e9vesque C, M\u00e9rand Y, Dufour JM, Labrie C, Labrie F: Synthesis and biological activity of new halosteroidal antiestrogens. J Med Chem, 1991, in press.","DOI":"10.1021\/jm00109a014"},{"key":"BF01806369_CR31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(86)80125-5","volume":"141","author":"JF Hubert","year":"1986","unstructured":"Hubert JF, Vincent A, Labrie F: Estrogenic activity of phenol red in rat anterior pituitary cells in culture. Biochem Biophys Res Commun 141: 885\u2013891, 1986","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01806369_CR32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0022-4731(84)90347-9","volume":"20","author":"CM Taylor","year":"1984","unstructured":"Taylor CM, Blanchard B, Zava DT: A simple method to determine whole cell uptake of radiolabeled estrogens and progesterone and their subcellular localization in breast cancer cell lines in monolayer cultures. J Steroid Biochem 20: 1083\u20131088, 1984","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR33","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/endo-94-5-1427","volume":"94","author":"D Rodbard","year":"1974","unstructured":"Rodbard D: Apparent positive cooperative effect in cyclic AMP and corticosterone production by isolated adrenal cells in response to ACTH analogues. Endocrinology 94: 1427\u20131437, 1974","journal-title":"Endocrinology"},{"key":"BF01806369_CR34","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng Y, Prusoff WH: Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099\u20133108, 1973","journal-title":"Biochem Pharmacol"},{"key":"BF01806369_CR35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10799898809049010","volume":"8","author":"PJ Munson","year":"1988","unstructured":"Munson PJ, Rodbard D: An exact correction to the \u2018Cheng-Prusoff\u2019 correction. J Receptor Res 8: 533\u2013546, 1988","journal-title":"J Receptor Res"},{"key":"BF01806369_CR36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/endo-125-1-392","volume":"125","author":"R Poulin","year":"1989","unstructured":"Poulin R, Simard J, Labrie C, Petitclerc L, Dumont M, Lagac\u00e9 L, Labrie F: Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. Endocrinology 125: 392\u2013399, 1989","journal-title":"Endocrinology"},{"key":"BF01806369_CR37","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/jcem-53-4-836","volume":"53","author":"JH MacIndoe","year":"1981","unstructured":"MacIndoe JH, Etre LA: An antiestrogenic action of androgens in human breast cancer cells. J Clin Endocrinol Metab 53: 836\u2013842, 1981","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01806369_CR38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0022-4731(86)90115-9","volume":"24","author":"F Vilchis","year":"1986","unstructured":"Vilchis F, Chavez B, P\u00e9rez AE, Garcia GA, Angeles A, P\u00e9rez-Palacios G: Evidence that a non-aromatizable metabolite of norethisterone induces estrogen-dependent pituitary progesterone receptors. J Steroid Biochem 24: 525\u2013531, 1986","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0022-4731(87)90134-8","volume":"27","author":"F Larrea","year":"1987","unstructured":"Larrea F, Vilchis F, Chavez B, P\u00e9rez-Palacios G: The metabolism of 19-nor contraceptive \u2018progestins\u2019 modulates their biological activity at the neuroendocrine level. J Steroid Biochem 27: 657\u2013663, 1987","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9378(79)90467-8","volume":"133","author":"WE Braselton","year":"1979","unstructured":"Braselton WE, Lin TJ, Ellegood JD, Mills TM, Mahesh VB: Accumulation of norethindrone and individual metabolites in human plasma during short-term and long-term administration of a contraceptive dosage. Am J Obstet Gynecol 133: 154\u2013169, 1979","journal-title":"Am J Obstet Gynecol"},{"key":"BF01806369_CR41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0022-4731(87)90014-8","volume":"26","author":"BL Sahlberg","year":"1987","unstructured":"Sahlberg BL, Landgren BM, Axelson M: Metabolic profiles of endogenous and ethynyl steroids in plasma and urine from women during administration of oral contraceptives. J Steroid Biochem 26: 609\u2013617, 1987","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0022-4731(87)90060-4","volume":"26","author":"BL Sahlberg","year":"1987","unstructured":"Sahlberg BL: The characterization of sulfated metabolites of norethindrone in human milk after oral administration of contraceptive steroids. J Steroid Biochem 26: 481\u2013485, 1987","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0303-7207(85)90023-1","volume":"41","author":"E Perel","year":"1985","unstructured":"Perel E, Daniilescu D, Kharlip L, Blackstein ME, Killinger DW: The relationship between growth and androstenedione metabolism in four cell lines of human breast carcinoma cells in culture. Mol Cell Endocrinol 41: 197\u2013203, 1985","journal-title":"Mol Cell Endocrinol"},{"key":"BF01806369_CR44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/acta.0.0680219","volume":"68","author":"E Gerhards","year":"1971","unstructured":"Gerhards E, Hecker W, Hitze H, Nieuweboer B, Bellman O: Zum Stoffwechsel von Norethisteron (17\u03b1-\u00c4thinyl-4-\u00f6stren-17\u03b2-ol-3-on) und diesowie D-Norgestrel (18-methyl-17\u03b1-\u00c4thinyl-4-\u00f6stren-17\u03b2-ol-3-on) beim Menschen. Acta Endocrinol (Copenh) 68: 219\u2013248, 1971","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BF01806369_CR45","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/endo-103-5-1768","volume":"103","author":"LP Bullock","year":"1978","unstructured":"Bullock LP, Bardin CW, Sherman MR: Androgenic, antiandrogenic, and synandrogenic actions of \u2018progestins\u2019: role of steric and allosteric interactions with androgen receptors. Endocrinology 103: 1768\u20131782, 1978","journal-title":"Endocrinology"},{"key":"BF01806369_CR46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0163-7258(88)90107-6","volume":"36","author":"AA Sandberg","year":"1988","unstructured":"Sandberg AA, Kirdani RY: Metabolism of natural and synthetic steroids used in cancer treatment. Pharmac Ther 36: 263\u2013307, 1988","journal-title":"Pharmac Ther"},{"key":"BF01806369_CR47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0022-4731(86)90323-7","volume":"25","author":"KB Horwitz","year":"1986","unstructured":"Horwitz KB, Pike AW, Gonzalez-Allen C, Fennessey PV: Progesterone metabolism in T47Dco human breast cancer cells. II. Intracellular metabolic path of progesterone and synthetic progestins. J Steroid Biochem 25: 911\u2013916, 1986","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0022-4731(80)90264-2","volume":"12","author":"JP Raynaud","year":"1980","unstructured":"Raynaud JP, Bouton MM, Moguilewsky M, Ojasoo T, Philibert D, Beck G, Labrie F, Mormon JP: Steroid hormone receptors and pharmacology. J Steroid Biochem 12: 143\u2013157, 1980","journal-title":"J Steroid Biochem"},{"key":"BF01806369_CR49","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/1097-0142(19840915)54:1+<1208::AID-CNCR2820541319>3.0.CO;2-K","volume":"54","author":"HC Blossey","year":"1984","unstructured":"Blossey HC, Wander HE, Kobberling J, Nagel GA: Pharmacokinetic and pharmocodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer 54: 1208\u20131215, 1984","journal-title":"Cancer"},{"key":"BF01806369_CR50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0277-5379(82)90191-2","volume":"18","author":"B Clavel","year":"1982","unstructured":"Clavel B, Pichon MF, Pallud C, Milgrom E: Estradiol and progesterone receptors content and response to norethisterone treatment in advanced breast cancer. Eur J Cancer Clin Oncol 18: 821\u2013826, 1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01806369_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0277-5379(84)90031-2","volume":"20","author":"J Alexieva-Figusch","year":"1984","unstructured":"Alexieva-Figusch J, Blankenstein MA, Hop WCJ, Klijn JGM, Lamberts SWJ, de Jong FH, Docter R, Adlercreutz H, Van Gilse HA: Treatment of metastatic breast cancer patients with different dosages of megestrol acetate: dose relations, metabolism and endocrine effects. Eur J Cancer Clin Oncol 20: 33\u201340, 1984","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01806369_CR52","first-page":"9","volume":"13","author":"DS Ettinger","year":"1986","unstructured":"Ettinger DS, Allegra J, Bertino JR, et al: Megestrol acetate vs. tamoxifen in advanced breast cancer: correlation of hormone receptors and response. Semin Oncol 13: 9\u201314, 1986","journal-title":"Semin Oncol"},{"key":"BF01806369_CR53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-3-642-82188-2_36","volume":"91","author":"J Alexieva-Figusch","year":"1984","unstructured":"Alexieva-Figusch J, Teulings FAG, Hop WCJ, Blonk-van der Wijst J, van Gilse HA: Steroid receptors in megestrol acetate therapy. Rec Results Cancer Res 91: 253\u2013258, 1984","journal-title":"Rec Results Cancer Res"},{"key":"BF01806369_CR54","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/02841868909092313","volume":"28","author":"S Lundgren","year":"1989","unstructured":"Lundgren S, Kvinnsland S, Utaaker E: Oral high-dose progestins as treatment for advanced breast cancer. Acta Oncol 28: 811\u2013816, 1989","journal-title":"Acta Oncol"},{"key":"BF01806369_CR55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF01486845","volume":"61","author":"HE Wanger","year":"1983","unstructured":"Wanger HE, Blossey Ch, K\u00f6bberling J, Nagel GA: Hochdosiertes Medroxyprogesteronacetat beim metastasierenden Mammakarzinom: Beziehung zwischen Krankheitsverlauf und Hormonprofilen. Klin Wochenschr 61: 553\u2013560, 1983","journal-title":"Klin Wochenschr"},{"key":"BF01806369_CR56","first-page":"103","volume":"10","author":"HM Earl","year":"1984","unstructured":"Earl HM, Rubens RD, Knight RK, Hayward JL: Norethisterone acetate in the treatment of advanced breast cancer. Clin Oncol 10: 103\u2013109, 1984","journal-title":"Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806369\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:43:55Z","timestamp":1557402235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,1]]}},"alternative-id":["BF01806369"],"URL":"https:\/\/doi.org\/10.1007\/bf01806369","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,1]]}}}